JM Financial Private Equity Fund II has finalised an investment of Rs 45 crore in Mumbai-based nutraceutical company Innovcare Lifesciences.
This marks the closing of the fifth investment by the fund, the company said in a statement.
On Wednesday, sources told BusinessLine that Innovcare Lifesciences would use the funds for its expansion plans.
Read: JM Financial’s PE arm invests ₹45 cr in Mumbai-based Innovcare Lifesciences
"Partnering with entrepreneurs and management teams with the vision to build scalable and sustainable businesses has been the key focus of JM Financial Private Equity. The fund infusion will help Innovcare in expanding its product portfolio in a more aggressive manner," Darius Pandole, Managing Director and CEO, PE & Equity AIFs, said.
Advisors for the deal included o3 Capital and Economic Laws Practice.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.